EUVIMEDEUVIMED entdecken
Crossref

Abnormal carnitine metabolism in hemodialysis patients on different anticoagulants

Kie Sekiguchi iD, Takaya Abe, Ei Shiomi, Daiki Ikarashi, Tomohiko Matsuura, Shigekatsu Maekawa, Renpei Kato, Mitsugu Kanehira, Ryo Takata, Jun Sugimura, Takashi Sekiguchi, Wataru Obara

Therapeutic Apheresis and Dialysis · 2024

DOI: 10.1111/1744-9987.14096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2024. Verfasst von Kie Sekiguchi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, School of Medicine, Iwate Medical University, Morioka, Iwate, Japan. Hauptthemen laut MEDLINE: Carnitine, Renal Dialysis, Anticoagulants. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

We aimed to determine whether unfractionated heparin (UH) and low molecular weight heparin (LH) contribute to aberrant carnitine metabolism in patients receiving hemodialysis.

Methods

The rate of increase in serum free fatty acids (FFAs) and the ratio of acylcarnitine to free carnitine (AC/FC) from before to after hemodialysis were determined in patients receiving UH and LH. Additionally, the effect of switching patients to UH from LH was examined.

Results

AC/FC was significantly higher in the UH group. In addition, serum FFAs in that group increased to 0.825 ± 0.270 after dialysis from 0.172 ± 0.160 before dialysis, showing a positive correlation with AC/FC. Furthermore, AC/FC was observed to be significantly higher in patients who were switched to UH from LH at 3 months after the change.

Conclusion

Compared with UH, LH has a lesser effect on lipid metabolism, suggesting that it also has a lesser effect on carnitine metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarnitineRenal DialysisAnticoagulantsHumansMaleFemaleMiddle AgedAgedHeparinHeparin, Low-Molecular-WeightFatty Acids, NonesterifiedLipid Metabolism

Stichwörter der Autor:innen

AC/FC ratioFFAcarnitine metabolismhemodialysisheparin

Substanzen

CarnitineAnticoagulantsHeparinHeparin, Low-Molecular-WeightFatty Acids, Nonesterifiedacylcarnitine

Autor:innen und Institutionen

  • Department of Urology, School of Medicine, Iwate Medical University, Morioka, Iwate, Japan.
  • Sekiguchi Internal Clinic, Hachinohe, Japan.

ORCID-Profile: Kie Sekiguchi

Zitieren

APA

Sekiguchi, K., Abe, T., Shiomi, E., Ikarashi, D., Matsuura, T., Maekawa, S., Kato, R., Kanehira, M., Takata, R., Sugimura, J., Sekiguchi, T., & Obara, W. (2024). Abnormal carnitine metabolism in hemodialysis patients on different anticoagulants. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14096

Vancouver

Sekiguchi K, Abe T, Shiomi E, Ikarashi D, Matsuura T, Maekawa S, et al. Abnormal carnitine metabolism in hemodialysis patients on different anticoagulants. Therapeutic Apheresis and Dialysis. 2024. doi:10.1111/1744-9987.14096

BibTeX
@article{Sekiguchi2024,
  author = {Sekiguchi, Kie and Abe, Takaya and Shiomi, Ei and Ikarashi, Daiki and Matsuura, Tomohiko and Maekawa, Shigekatsu and Kato, Renpei and Kanehira, Mitsugu and Takata, Ryo and Sugimura, Jun and Sekiguchi, Takashi and Obara, Wataru},
  title = {Abnormal carnitine metabolism in hemodialysis patients on different anticoagulants},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2024},
  doi = {10.1111/1744-9987.14096}
}
Kostenlos starten →